Stock Events

Stock Events

IQVIA 

$272.00
136
+$0.38+0.14% 10:17 Today

Statistics

Day High
271.71
Day Low
271.33
52W High
271.69
52W Low
154.5
Volume
65,309
Avg. Volume
-
Mkt Cap
44.71B
P/E Ratio
25.85
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
2.63
2.9
3.16
3.42
Expected EPS
3.266382
Actual EPS
N/A

Financials

8.34%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
16.31BRevenue
1.36BNet Income

Analyst Ratings

252.00Average Price Target
The highest estimate is 288.00.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy
89%
Hold
11%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IQV. It's not an investment recommendation.
Microsoft
51
MSFT
Amazon
49
AMZN
NVIDIA
46
NVDA
Apple
44
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Charles River Laboratories International
CRL
Mkt Cap13.92B
Charles River Laboratories provides a variety of preclinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology industries, competing directly with IQVIA's research services.
Icon Energy
ICON
Mkt Cap3.55M
ICON plc offers clinical research services, directly competing with IQVIA in the contract research organization (CRO) space, providing full-service clinical development services.
Medpace
MEDP
Mkt Cap16.77B
Medpace Holdings is a scientifically-driven, global full-service clinical contract research organization (CRO) that competes with IQVIA in providing phase I-IV clinical development services to the pharmaceutical and biotech industry.
Mettler-Toledo International
MTD
Mkt Cap28.02B
Mettler-Toledo International Inc. provides precision instruments and services for professional use, including drug development and research, overlapping with some of IQVIA's analytical and laboratory services.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific Inc. offers analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with IQVIA in the life sciences and laboratory services market.
Quest Diagnostics
DGX
Mkt Cap26.79B
Quest Diagnostics Incorporated provides diagnostic testing, information, and services, including clinical trials testing which competes with IQVIA's services in the healthcare and diagnostics market.

About

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Show more...
CEO
Ari Bousbib
Employees
94000
Country
United States
ISIN
US46266C1053
WKN
000A2JSPM

Listings

MI
IT
1IQV.MI
LSE
GB
0JDM.LSE
MU
DE
QTS.MU
XETRA
DE
QTS.XETRA

0 Comments

Share your thoughts

FAQ

What is IQVIA stock price today?▼
The current price of IQV is $272.00 USD — it has increased by +0.14% in the past 24 hours. Watch IQVIA stock price performance more closely on the chart.
What is IQVIA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange IQVIA stocks are traded under the ticker IQV.
Is IQVIA stock price growing?▼
IQV stock has risen by +3.77% compared to the previous week, the month change is a +19.03% rise, over the last year IQVIA has showed a +47.56% increase.
What is IQVIA market cap?▼
Today IQVIA has the market capitalization of 44.71B
When is the next IQVIA earnings date?▼
IQVIA is going to release the next earnings report on November 04, 2026.
What were IQVIA earnings last quarter?▼
IQV earnings for the last quarter are 3.15 USD per share, whereas the estimation was 3.03 USD resulting in a +3.89% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is IQVIA revenue for the last year?▼
IQVIA revenue for the last year amounts to 16.31B USD.
What is IQVIA net income for the last year?▼
IQV net income for the last year is 1.36B USD.
How many employees does IQVIA have?▼
As of September 04, 2026, the company has 94,000 employees.
In which sector is IQVIA located?▼
IQVIA operates in the Health & Wellness sector.
When did IQVIA complete a stock split?▼
IQVIA has not had any recent stock splits.
Where is IQVIA headquartered?▼
IQVIA is headquartered in DURHAM, United States.